Ocular toxoplasmosis treatment and clinical monitoring of the patient.
A case of ocular toxoplasmosis is presented from the initial patient contact to the completion of treatment. A discussion follows which reviews the literature on ocular toxoplasmosis with emphasis on the typical pharmacological management of the disease.
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002825:Chorioretinitis / Q000175:diagnosis* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D011239:Prednisolone; D011241:Prednisone / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis* / Q000188:drug therapy; D014326:Tropanes / Q000627:therapeutic use; D014605:Uveitis / Q000175:diagnosis* / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D013449:Sulfonamides; D014326:Tropanes; C100236:homatropine; D011239:Prednisolone; D011241:Prednisone; D011739:Pyrimethamine